Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients

被引：1

作者：

Musto, Pellegrino ^{[1
]}

Fraticelli, Vincenzo Ludovico ^{[2
]}

Mansueto, Giovanna ^{[1
]}

D'Arena, Giovanni ^{[1
]}

Petrilli, Maria Pia ^{[2
]}

Gasbarrino, Cristiana ^{[2
]}

Farina, Giuliana ^{[2
]}

Guariglia, Roberto ^{[1
]}

Martorelli, Maria Carmen ^{[1
]}

Villani, Oreste ^{[1
]}

Pietrantuono, Giuseppe ^{[1
]}

Catalano, Lucio ^{[3
]}

Madonna, Emanuela ^{[3
]}

Nozza, Andrea ^{[3
]}

Andriani, Alessandro ^{[3
]}

Montefusco, Vittorio ^{[3
]}

Mussetti, Alberto ^{[3
]}

Lipari, Maria Grazia ^{[3
]}

Ballanti, Stelvio ^{[3
]}

Bongarzoni, Velia ^{[3
]}

Tamiazzo, Stefania ^{[3
]}

Patriarca, Francesca ^{[3
]}

Vincelli, Donatella ^{[3
]}

Falcone, Antonietta ^{[3
]}

Derudas, Daniele ^{[3
]}

Califano, Catello ^{[3
]}

Zambello, Renato ^{[3
]}

Mele, Giuseppe ^{[3
]}

Fragasso, Alberto ^{[3
]}

Baldini, Luca ^{[3
]}

Palumbo, Antonio ^{[4
]}

Storti, Sergio ^{[2
]}

机构：

[1] IRCCS, CROB, Rionero In Vulture, Pz, Italy

[2] UOC Oncohematol, Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy

[3] GIMEMA Multiple Myeloma Working Party & Italian M, Rome, Italy

[4] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2971.2971

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2971

引用

页数：2

共 50 条

[1] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma
Stoehr, Elisabeth
Schmeel, Frederic Carsten
Schmeel, Leonard Christopher
Haenel, Mathias
Schmidt-Wolf, Ingo G. H.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2205 - 2212
[2] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma
Elisabeth Stöhr
Frederic Carsten Schmeel
Leonard Christopher Schmeel
Mathias Hänel
Ingo G. H. Schmidt-Wolf
Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2205 - 2212
[3] Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
Kim, Seok Jin
Bang, Soo-Mee
Choi, Yoon Seok
Jo, Deog-Yeon
Kim, Jin Seok
Lee, Hyewon
Eom, Hyeon Seok
Yoon, Dok Hyun
Suh, Cheolwon
Lee, Je-Jung
Hong, Junshik
Lee, Jae Hoon
Koh, Youngil
Kim, Kihyun
Yoon, Sung-Soo
Min, Chang-Ki
BLOOD RESEARCH, 2016, 51 (03) : 193 - 199
[4] A Real-World Study of Bendamustine Therapy in a Very Heavily Pre-Treated Population of Multiple Myeloma Patients
Bird, Sarah
Panopoulou, Akaterina
Kaiser, Martin
Boyd, Kevin
Pawlyn, Charlotte
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S424 - S424
[5] Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma
Papanikolaou, Xenofon
Szymonifka, Jackie
Rosenthal, Adam
Heuck, Christoph J.
Mitchell, Alan
Johann, Donald, Jr.
Keller, Jason
Waheed, Sarah
Usmani, Saad Z.
Van Rhee, Frits
Bailey, Clyde
Petty, Nathan
Hoering, Antje
Crowley, John
Barlogie, Bart
HAEMATOLOGICA, 2013, 98 (07) : 1147 - 1153
[6] UNDERSTANDING THE UTILITY VALUE OF PATIENTS WITH HEAVILY PRE-TREATED MULTIPLE MYELOMA
Hadi, M.
Swinburn, P.
de Freitas, H. M.
Ito, T.
VALUE IN HEALTH, 2016, 19 (07) : A389 - A389
[7] Bendamustine salvage for relapsed - refractory multiple myeloma: a retrospective analysis of outcomes in heavily pretreated patients
Singh, Aakanksha
Agrawal, Narendra
Haldar, Rohan
Bhurani, Dinesh
Raychoudhari, Jyoti Shankar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S211 - S211
[8] Contemporary Use of VTD-PACE As Bridge Therapy in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma
Kurish, Heena P.
Row, Kerri
Kurkowski, Austin
Rice, Mikhaila
Rudoni, Joslyn
Khouri, Jack
Mazzoni, Sandra
Samaras, Christy J.
Williams, Louis S.
van Heeckeren, Willem
Valent, Jason
Anwer, Faiz
BLOOD, 2022, 140 : 12496 - 12497
[9] COST-EFFECTIVENESS ANALYSIS OF DARATUMUMAB IN HEAVILY PRE-TREATED MULTIPLE MYELOMA PATIENTS FOR THE ITALIAN HEALTHCARE SYSTEM
Lo Muto, R.
Lenzi, M.
Franzini, J. M.
Baggi, A.
Bonetti, G.
Hegenbarth, A.
VALUE IN HEALTH, 2017, 20 (09) : A442 - A443
[10] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
Rupert Bartsch
Catharina Wenzel
Simon P. Gampenrieder
Ursula Pluschnig
Gabriela Altorjai
Margaretha Rudas
Robert M. Mader
Peter Dubsky
Andrea Rottenfusser
Michael Gnant
Christoph C. Zielinski
Guenther G. Steger
Cancer Chemotherapy and Pharmacology, 2008, 62 : 903 - 910

← 1 2 3 4 5 →